No abstract

No abstract

These data provide direct evidence that finasteride 1 mg daily promotes the conversion of hairs into the anagen phase. These data support that finasteride treatment results in favourable effects on hair quality that contribute to the visible improvements in hair growth observed in treated patients.

These results indicate that CE-PTG is a powerful tool for analysis of hair growth and loss and may cast some doubt on results obtained with other methods. The potential use of the CE-PTG method for calibration of innovative tools is also alluded to. Indeed encouraging results have been obtained with the scalp coverage scoring (SCS) method. These SCS scores were correlated with shortening of anagen phase and hair miniaturization, the two processes apparently involved in the clinical development of male AGA.

Most of these problems have been identified in the late 1980s and remain largely unsolved by the processing software that was evaluated in 2004. Therefore claims promoting the Trichoscan method for accurate hair measurements in clinical trials on scalp and body hair are not supported by the present investigation. The speed at which the analysis is performed is outweighed by the errors in signal detection. Therefore we suggest that improvements must be clearly documented before Trichoscan is established for quantified diagnostic purposes and detailed hair cycle monitoring during hair trials.